Evidence map›Paper›PMID 41127015›Full record

ArticleFrontiers in oncology2025

CT-based radiomics nomogram for differentiating dedifferentiated liposarcoma from well-differentiated liposarcoma.

Ting Yang, Ruo-Yu Chen, Yi-Fan Ding, Jing-Yan Wu, Ying Li, Jin-Wei Qiang

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Liposarcoma: State of the Art-A Scoping Review.Medical sciences (Basel, Switzerland) · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ting Yang *Department of Radiology, Jinshan Hospital of Fudan University, Shanghai, China.
Ruo-Yu Chen *Department of Radiology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Yi-Fan DingDepartment of Radiology, Jinshan Hospital of Fudan University, Shanghai, China.
Jing-Yan WuDepartment of Radiology, Jinshan Hospital of Fudan University, Shanghai, China.
Ying LiDepartment of Radiology, Jinshan Hospital of Fudan University, Shanghai, China.
Jin-Wei QiangDepartment of Radiology, Jinshan Hospital of Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study aimed to use radiomics features derived from plain CT scans to construct a model that can predict the pathological classification of Retroperitoneal liposarcoma (RLPS) preoperatively, help enhance preoperative planning and inform tailored treatment strategies. Methods: This retrospective study involving 114 consecutive RLPS patients from January 2022 to December 2024. Clinical, pathological, and CT imaging data were gathered. Radiomics features were extracted from plain CT scans and were selected through Least Absolute Shrinkage and Selection Operator (LASSO) regression. A radiomics signature was created, and a nomogram was developed for predicting dedifferentiated liposarcoma (DDLPS). Performance of the nomogram was assessed and compared with radiologist evaluation of the CT imaging. Area under the curve (AUC) and decision curve analysis in both training and validation sets. Results: Higher Ki-67 and unclear tumor boundary was established as an independent predictor for DDLPS. Five radiomics features were identified as significant predictors. a nomogram was developed by combining these features. The nomogram showed an AUC of 0.91 (95% CI: 0.84-0.98) and 0.89 (95% CI: 0.73-1.00) in the training and validation set, which outperforming the radiologist evaluation. Decision curve analysis confirmed that the nomogram provided a higher net clinical benefit compared to the radiologist. Conclusions: The radiomics nomogram significantly enhances the preoperative differentiation of RLPS subtypes.

Indexed as

CT scanKi-67nomogramradiomicsretroperitoneal liposarcoma

Identifiers

PMID41127015
PMCPMC12538513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.